Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Chimeric antigen receptors (CARs) are synthetic receptor proteins that have been engineered to give T cells the ability to recognize and bind to specific proteins, or antigens, on the surface of cancer cells
Adoptive T Cell Therapy / CAR-T uses T cells that have been genetically modified to express CARs to treat cancer.
Chimeric antigen receptor (CAR) expressing immune cells could be redirected towards Tumor-associated carbohydrates (TACA)-presenting tumors.
Mantuano et al. 2020
Chimeric antigen receptors (CAR) functionally redirect T cells with high specificity to surface antigens on tumor cells independent of MHC restriction and [antigen proc…